CN104621574A - Formula food suitable for diabetic patients and preparation method thereof - Google Patents
Formula food suitable for diabetic patients and preparation method thereof Download PDFInfo
- Publication number
- CN104621574A CN104621574A CN201510057275.3A CN201510057275A CN104621574A CN 104621574 A CN104621574 A CN 104621574A CN 201510057275 A CN201510057275 A CN 201510057275A CN 104621574 A CN104621574 A CN 104621574A
- Authority
- CN
- China
- Prior art keywords
- patients
- buckwheat
- raw material
- cobastab
- subsequent use
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 44
- 235000013305 food Nutrition 0.000 title claims abstract description 34
- 238000002360 preparation method Methods 0.000 title claims description 9
- 235000009419 Fagopyrum esculentum Nutrition 0.000 claims abstract description 28
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 21
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 21
- 235000019742 Vitamins premix Nutrition 0.000 claims abstract description 16
- 238000002156 mixing Methods 0.000 claims abstract description 16
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 15
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 15
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 15
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 15
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 15
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 15
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 15
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 15
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 15
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 15
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims abstract description 15
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims abstract description 15
- 235000010447 xylitol Nutrition 0.000 claims abstract description 15
- 239000000811 xylitol Substances 0.000 claims abstract description 15
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims abstract description 15
- 229960002675 xylitol Drugs 0.000 claims abstract description 15
- 239000000835 fiber Substances 0.000 claims abstract description 14
- 235000013373 food additive Nutrition 0.000 claims abstract description 13
- 239000002778 food additive Substances 0.000 claims abstract description 13
- 238000001035 drying Methods 0.000 claims abstract description 9
- 241000219051 Fagopyrum Species 0.000 claims description 27
- 239000002994 raw material Substances 0.000 claims description 27
- 239000000463 material Substances 0.000 claims description 20
- 239000000843 powder Substances 0.000 claims description 19
- 241001092040 Crataegus Species 0.000 claims description 14
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 12
- 238000010298 pulverizing process Methods 0.000 claims description 10
- 210000000582 semen Anatomy 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 150000003904 phospholipids Chemical class 0.000 claims description 7
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 6
- 229930003268 Vitamin C Natural products 0.000 claims description 6
- 238000004140 cleaning Methods 0.000 claims description 6
- 239000012535 impurity Substances 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 235000019154 vitamin C Nutrition 0.000 claims description 6
- 239000011718 vitamin C Substances 0.000 claims description 6
- 235000020717 hawthorn extract Nutrition 0.000 claims description 5
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 4
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 4
- 238000007789 sealing Methods 0.000 claims description 4
- 235000019155 vitamin A Nutrition 0.000 claims description 4
- 239000011719 vitamin A Substances 0.000 claims description 4
- 229940045997 vitamin a Drugs 0.000 claims description 4
- 239000005913 Maltodextrin Substances 0.000 claims description 3
- 229920002774 Maltodextrin Polymers 0.000 claims description 3
- 238000007654 immersion Methods 0.000 claims description 3
- 229940035034 maltodextrin Drugs 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- 239000008213 purified water Substances 0.000 claims description 3
- 238000001694 spray drying Methods 0.000 claims description 3
- 210000004369 blood Anatomy 0.000 abstract description 9
- 239000008280 blood Substances 0.000 abstract description 9
- 208000024891 symptom Diseases 0.000 abstract description 9
- 230000000694 effects Effects 0.000 abstract description 5
- 239000008103 glucose Substances 0.000 abstract description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 2
- 240000000171 Crataegus monogyna Species 0.000 abstract 1
- 240000008620 Fagopyrum esculentum Species 0.000 abstract 1
- 235000021307 Triticum Nutrition 0.000 abstract 1
- 241000209140 Triticum Species 0.000 abstract 1
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 abstract 1
- 238000007670 refining Methods 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 235000005911 diet Nutrition 0.000 description 8
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 8
- 235000015097 nutrients Nutrition 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 238000002560 therapeutic procedure Methods 0.000 description 5
- 102000004877 Insulin Human genes 0.000 description 4
- 108090001061 Insulin Proteins 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- 230000000378 dietary effect Effects 0.000 description 4
- 229940125396 insulin Drugs 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 150000003722 vitamin derivatives Chemical class 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 3
- RADKZDMFGJYCBB-UHFFFAOYSA-N Pyridoxal Chemical compound CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- 208000002249 Diabetes Complications Diseases 0.000 description 2
- 206010012655 Diabetic complications Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- NHZMQXZHNVQTQA-UHFFFAOYSA-N pyridoxamine Chemical compound CC1=NC=C(CO)C(CN)=C1O NHZMQXZHNVQTQA-UHFFFAOYSA-N 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000037394 skin elasticity Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- CDAISMWEOUEBRE-LKPKBOIGSA-N 1D-chiro-inositol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O CDAISMWEOUEBRE-LKPKBOIGSA-N 0.000 description 1
- 102000016912 Aldehyde Reductase Human genes 0.000 description 1
- 108010053754 Aldehyde reductase Proteins 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 102000040350 B family Human genes 0.000 description 1
- 108091072128 B family Proteins 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 108010004460 Gastric Inhibitory Polypeptide Proteins 0.000 description 1
- 102100039994 Gastric inhibitory polypeptide Human genes 0.000 description 1
- 102000051325 Glucagon Human genes 0.000 description 1
- 108060003199 Glucagon Proteins 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 102000003746 Insulin Receptor Human genes 0.000 description 1
- 108010001127 Insulin Receptor Proteins 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 208000022329 Protein metabolism disease Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000001800 adrenalinergic effect Effects 0.000 description 1
- 230000037354 amino acid metabolism Effects 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000000496 cardiotonic agent Substances 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 235000012721 chromium Nutrition 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000001904 diabetogenic effect Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000002384 drinking water standard Substances 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 238000009207 exercise therapy Methods 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 230000030136 gastric emptying Effects 0.000 description 1
- 239000003629 gastrointestinal hormone Substances 0.000 description 1
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 1
- 229960004666 glucagon Drugs 0.000 description 1
- 230000004153 glucose metabolism Effects 0.000 description 1
- 230000006377 glucose transport Effects 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000033065 inborn errors of immunity Diseases 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000003050 macronutrient Effects 0.000 description 1
- 235000021073 macronutrients Nutrition 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 206010062198 microangiopathy Diseases 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 210000000633 nuclear envelope Anatomy 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000004203 pancreatic function Effects 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 210000002706 plastid Anatomy 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 229960003581 pyridoxal Drugs 0.000 description 1
- 235000008164 pyridoxal Nutrition 0.000 description 1
- 239000011674 pyridoxal Substances 0.000 description 1
- 235000008151 pyridoxamine Nutrition 0.000 description 1
- 239000011699 pyridoxamine Substances 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 235000011649 selenium Nutrition 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000001839 systemic circulation Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 235000016804 zinc Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention provides a formula food suitable for diabetic patients. The formula food is prepared by refining, concentrating, drying and mixing buckwheat, wheat fibre, hawthorn, the root of kudzu vine, isomalto-oligosaccharide, xylitol, food additives and vitamin premix in certain percentages. The formula food disclosed by the invention is free from toxic and side effect; and in addition, after being eaten by patients, the formula food is capable of effectively reducing blood glucose of patients and relieving clinical symptoms of patients.
Description
Technical field
The present invention relates to food, be specifically related to a kind of formula food being applicable to patients with diabetes mellitus, the invention still further relates to the preparation method of this food.
Background technology
Diabetes are common multiple diseases of a kind of serious harm human health, and its complication is extensively serious, and at present, diabetic has the trend increased year by year in the world.Because in patient body, insulin lacks relatively or definitely, cause sugar, fat, protein metabolism disorder, cause the rising of hyperglycaemia, high fat of blood and blood viscosity, there is the whole body extensively microangiopathies in middle and advanced stage, major part patient dies from cardiovascular disease, and diabetes kidney function failure and cerebrovas-cularaccident are the common causes of death of middle and elderly diabetic patient.
There is no the method for radical cure diabetes at present, but diabetes can be controlled well by multiple treatment means.Mainly comprise 5 aspects: the education of diabetic, self-monitoring of blood glucose, dietary therapy, exercise therapy and drug therapy.For diabetic, reasonable diet is the prerequisite for the treatment of diabetes, is also most important, a most basic ring.Dietary therapy is the basis of all kinds treating diabetes, and by correct dietary therapy, control sugar in food, fat, protein content, the alone dietary therapy of a part of levis diabetes patient just can symptom management.Diet management in diabetes is not can not eat to drink, but will adhere to that scientific and reasonable diet collocation reaches the object of symptom management.
Summary of the invention
Technical problem to be solved by this invention is to provide a kind of formula food being applicable to patients with diabetes mellitus, this food of edible for patients, self resistance against diseases and symptom management ability can be improved, thus realize the object that Diabetes Mellitus is eased and controls.
For solving the problems of the technologies described above, the technical solution used in the present invention is: a kind of formula food being applicable to patients with diabetes mellitus, is made up of following raw material:
Buckwheat 33%-37%, Semen Tritici aestivi fiber 25%-29%, hawthorn 8%-12%, the root of kudzu vine 1%-3%, oligoisomaltose 3%-7%, xylitol 3%-7%, food additives 13%-17%, vitamin premix 0.1%-0.5%.
Wherein, described vitamin premix is Cobastab in every 100g vitamin premix
1containing 2mg, Cobastab
2containing 2mg, Cobastab
6containing 2mg, vitamin A is containing 0.5mg, and vitamin C is containing 195.5mg, and surplus is maltodextrin.
Described food additives are powdered phospholipid.
Described buckwheat is buckwheat after dried, crushed.
Described hawthorn is haw thorn extract, be extract through poach, concentrated, drying and crushing obtains.
The described root of kudzu vine is kudzu root extract, be extract through poach, concentrated, drying and crushing obtains.
The present invention is applicable to the formula food of patients with diabetes mellitus, and its preparation method step is:
(1). the impurity in the root of kudzu vine, hawthorn, foreign matter and the raw material that do not meet quality standard are carried out picking picking cleaning, drop into the purified water adding material quantity 10 times carry out immersion 30 minutes by picking the raw material after picking cleaning, soak well and decoct 1 hour at 100 DEG C of temperature, extract 2 hours at 100 DEG C of temperature again, last temperature 80 DEG C, 2 hours are concentrated under pressure-0.08Mpa, centrifugal spray drying is carried out to during relative density 1.1, dried crushing material is become 100 object powders, seals up for safekeeping for subsequent use in the material charging feedstock bucket after pulverizing;
(2). the impurity in buckwheat, foreign matter and the raw material that do not meet quality standard are carried out picking picking, then the buckwheat chosen is put into drying equipment and carry out drying, temperature controls at 110 DEG C, 30 minutes time, lower the temperature after dried, dried buckwheat is broken into 100 object powders, for subsequent use sealing up for safekeeping in the material charging feedstock bucket after pulverizing;
(3). it is for subsequent use that the buckwheat of the root of kudzu vine processed, haw thorn extract and process to add in mixer Homogeneous phase mixing 15 minutes, and standard is uniform powder;
(4). it is for subsequent use powdered phospholipid, xylitol, oligoisomaltose to be added in mixer Homogeneous phase mixing 15 minutes, and standard is uniform powder;
(5). Cobastab
1, Cobastab
2, Cobastab
6, that VC, VA to add in mixer Homogeneous phase mixing 15 minutes is for subsequent use, standard is uniform powder;
(6). it is for subsequent use (3) step and the mixed material of (4) step to be added in mixer Homogeneous phase mixing 15 minutes, and standard is uniform powder;
(7). (5) step and the mixed material of (6) step are added in mixer to carry out Homogeneous phase mixing 15 minutes for subsequent use, standard is uniform powder, and preparation completes.
Usage and dosage of the present invention: get this product 10g, adds warm water 100-150ml, is edible after stirring.
The present invention is according to the needs of diabetic to nutrient, targetedly nutrient is carried out supplementing and strengthened and (belong to non-fully nutritional formulas, according to special medicine purposes formula food nutrition component classification, belong to thickening assembly), the state of an illness of diabetic is controlled with this, the clinical symptoms of reduction of patient, as: many drink, diuresis, eat more, become thin and fatigue and weak, obesity etc.By the strengthening of specific nutrient with supplement, improve resistance against diseases and the symptom management ability of diabetic, thus the state of an illness realizing diabetic is controlled.
In each raw material of the present invention:
Buckwheat, containing abundant " rutin " composition, so be hypertension, medicinal food that diabetic is desirable.According to investigations, the area of normal edible buckwheat food, the people obtaining high blood pressure is obviously few than the people in not edible buckwheat food area.
Powdered phospholipid is a kind of mixed phosphatide, and phosphatide is the basis of human body cell (cell membrane, nuclear membrane, plastid film), has very high nutritive value and medical value.The effect that there is emulsification, cut grease, blood circulation can be promoted, improve serum lipids, remove peroxide, lecithin deficiency can make pancreas function decline, sufficient insulin cannot be secreted, can not effectively by the glucose transport in blood in cell, this leads one of diabetogenic fundamental cause.
Semen Tritici aestivi fiber, fiber diet acts on by gastric emptying, the intestines transhipment time changes, Soluble Fiber forms gel in intestines etc. and the absorption of sugar is slowed down.Also by reducing intestinal hormones as Gastric inhibitory polypeptide or glucagon secretion, reducing the stimulation to B cell, reduce insulin releasing and increase peripheral insulin receptor sensitivity, glucose metabolism is strengthened.
Oligoisomaltose, effectively can promote the growth and breeding of beneficial bacteria-Bifidobacterium in human body.
The root of kudzu vine, containing kudzu root flavone in the root of kudzu vine, has therapeutic action to the complication etc. that diabetes cause.
Hawthorn, haw thorn extract energy coronary artery dilator, increases coronary flow, Ischemic myocardium anoxic; And can cardiac stimulant, hypotensive and anti-arrhythmia; Reducing blood lipid, anti arteriosclerosis, reduces blood viscosity, slows down microcirculation disorder, the generation of control diabetic complication.
Xylitol, xylitol energy permeate through cell membranes is absorbed by tissue utilization, and can promote that liver glycogen synthesizes, and improves liver function, is the desirable food of diabetes and hepatitis concurrent disease patient.
Diabetes are due to metabolic disorder, and the nutrient that health lacks is a lot, not only lacks multiple Macronutrient, and more lack lot of trace nutrient, the micronutrient lacked most have chromium, zinc, selenium, vitamin C, vitamin A, Cobastab
1, B
2, B
6deng
Cobastab comprises Cobastab
1, B
2, B
6, B
12, nicotinic acid, pantothenic acid, folic acid etc.B family vitamin is push body intracellular metabolite, indispensable material when sugar, fat, protein etc. are changed into heat.
Cobastab
2, being riboflavin again, is a kind of needed by human vitamin, when lacking, just affecting the biological oxidation of body, making metabolism generation obstacle.Cobastab
2participating in the growth metabolism of cell, is the necessary nutrient of injected organism tissue metabolism and reparation, as strengthening liver function, regulates adrenergic secretion.
Cobastab
6, also known as pyridoxol, pyridoxal and pyridoxamine, be a kind of water soluble vitamin, B
6for the constituent of some coenzyme in human body, participate in multiple metabolic response, especially have substantial connection with amino acid metabolism.There is vomiting in tumor patient peri-operation period, the sign such as anorexia and hypoimmunity, and clinical research finds, Cobastab
6positive curative effect is had, Cobastab to vomiting, anorexia
6lack infringement cell and affect humoral immune function, giving Cobastab
6can immunity be improved, and have certain protective effect on cancer risk.
Vitamin C, is L-AA again, is a kind of water soluble vitamin.Cannot synthesize voluntarily in vivo, can only absorb from food or medicine.There is raising body immunity.Improve sterilizing ability, promote lymphoblastic generation, improve human body to the identification of external and malignant cell with kill, suppress the invasion of virus.Promote the biosynthesis of ossein, thus accelerating wound healing, contribute to treatment wound, burn, accelerate postoperative rehabilitation.Improve the metabolism of fat and lipoid particularly cholesterol; Help to reduce the cholesterol in blood, reduce the generation of thrombus in vein, prevention cardiovascular disease.Pre-anti-cancer.Strengthen skin elasticity, prevention color spot.Vitamin C is a kind of powerful antioxidant, can ensure the integrality of cell and normally carrying out of metabolism, strengthens skin elasticity.
The present invention adopts the formula food being applicable to patients with diabetes mellitus designed by technique scheme, and show through widely applying, have no side effect, patient adheres to eating, and effectively can reduce the blood sugar of patient, the clinical symptoms of reduction of patient.
Detailed description of the invention
This product is raw material based on fiber, phosphatide, for the needs of diabetic, be equipped with multiple have hypoglycemic special compound IP6 (D-chiro-inositol) is fallen, the effect similar with insulin can be played, can prevent or suppress the activity of aldose reductase, help the generation postponing or prevent diabetic complication.
Consisting of of each raw material of the present invention:
Buckwheat 33%-37%, Semen Tritici aestivi fiber 25%-29%, hawthorn 8%-12%, the root of kudzu vine 1%-3%, oligoisomaltose 3%-7%, xylitol 3%-7%, food additives 13%-17%, vitamin premix 0.1%-0.5%.
The present invention is applicable to the formula food embodiment 1 of patients with diabetes mellitus, is made up of following raw material:
Buckwheat 37%, Semen Tritici aestivi fiber 29%, hawthorn 12%, the root of kudzu vine 1%, oligoisomaltose 3%, xylitol 3%, food additives 14.9%, vitamin premix 0.1%.
The present invention is applicable to the formula food embodiment 2 of patients with diabetes mellitus, is made up of following raw material:
Buckwheat 35%%, Semen Tritici aestivi fiber 27%, hawthorn 10%, the root of kudzu vine 2%, oligoisomaltose 5%, xylitol 5%, food additives 15.7%, vitamin premix 0.3%.
The present invention is applicable to the formula food embodiment 3 of patients with diabetes mellitus, is made up of following raw material:
Buckwheat 33%, Semen Tritici aestivi fiber 25%, hawthorn 8%, the root of kudzu vine 3%, oligoisomaltose 7%, xylitol 7%, food additives 16.5%, vitamin premix 0.5%.
In the various embodiments described above, vitamin premix is Cobastab in every 100g vitamin premix
1containing 2mg, Cobastab
2containing 2mg, Cobastab
6containing 2mg, vitamin A is containing 0.5mg, and vitamin C is containing 195.5mg, and surplus is maltodextrin.
In the various embodiments described above, food additives are powdered phospholipid.
Preparation method's step of the above embodiment of the present invention is:
(1). the root of kudzu vine, hawthorn are carried out picking picking, picks the impurity picked out in raw material, foreign matter and do not meet the raw material of quality standard; Cleaning raw material water should meet national drinking water standard, and raw material washing should use circulating water, and must not be used for washing other raw materials with the water crossed, different raw materials should not wash together; Dropped in extractor by raw material after cleaning, the purified water adding material quantity 10 times carries out immersion 30 minutes; Soaked raw material decocts 1 hour, temperature 100 DEG C; Open systemic circulation and extract 2 hours, temperature 100 DEG C; Open concentrated again, concentration time is 2 hours, temperature 80 DEG C, and pressure-0.08Mpa, carries out centrifugal spray drying to during relative density 1.1; Dried material is added pulverizer and carries out 100 order pulverizing, after pulverizing, fineness uniformity should be kept; For subsequent use sealing up for safekeeping in the material charging feedstock bucket after pulverizing;
Dried material answer seal up for safekeeping in charging feedstock bucket for subsequent use;
(2). buckwheat is carried out picking picking, picks the impurity picked out in raw material, foreign matter and do not meet the raw material of quality standard; Then the buckwheat chosen is put into drying equipment and carry out drying, temperature controls at 110 DEG C, 30 minutes time, proceeds to terminal cooling after dried; Dried buckwheat is added pulverizer and carries out 100 order pulverizing, the buckwheat after pulverizing should keep fineness uniformity; For subsequent use sealing up for safekeeping in the material charging feedstock bucket after pulverizing;
(3). it is for subsequent use that the buckwheat of the root of kudzu vine processed, haw thorn extract and process to add in mixer Homogeneous phase mixing 15 minutes, and standard is uniform powder;
(4). it is for subsequent use powdered phospholipid, xylitol, oligoisomaltose to be added in mixer Homogeneous phase mixing 15 minutes, and standard is uniform powder;
(5). it is for subsequent use that vitamin B1, vitamin B2, vitamin B6, VC, VA to add in mixer Homogeneous phase mixing 15 minutes, and standard is uniform powder;
(6). it is for subsequent use (3) step and the mixed material of (4) step to be added in mixer Homogeneous phase mixing 15 minutes, and standard is uniform powder;
(7). (5) step and the mixed material of (6) step are added in mixer to carry out Homogeneous phase mixing 15 minutes for subsequent use, standard is uniform powder, and preparation completes.
The formula food that the present invention is applicable to patients with diabetes mellitus is configured by embodiment 2 and tests application clinically.According to the diagnostic criteria of WHO1999 diabetes, fasting blood-glucose >=7mmol ∕ L person is the object of observation, is 106 routine edible for patients in clinical altogether, wherein man 41 example, female 65 example, 30-40 year 2 example, 40-50 year 9 example, 50-60 year 27 examples, 60-70 year 46 examples, more than 70 years old 22 is routine.Patient is diabetic, shows as many drink, diuresis, eats more, becomes thin, fatigue and weak and obesity etc.Patient's three meals in a day take food 30-180 days of the present invention, get this product 10g at every turn, add warm water 100-150ml, are edible after stirring.Show through clinical practice, effective (symptom is obviously improved or disappeared) 68 is routine, accounts for 64%, and effectively (symptom makes moderate progress) 28 is routine, and account for 26%, total effective rate reaches 90%.The mental attitude of patient also significantly improves, show by the strengthening of food specific nutrient of the present invention with supplement, improve the resistance against diseases of diabetic self, reach the dual purpose of prevention and therapy.
Claims (7)
1. be applicable to a formula food for patients with diabetes mellitus, it is characterized in that being made up of following raw material:
Buckwheat 33%-37%, Semen Tritici aestivi fiber 25%-29%, hawthorn 8%-12%, the root of kudzu vine 1%-3%, oligoisomaltose 3%-7%, xylitol 3%-7%, food additives 13%-17%, vitamin premix 0.1%-0.5%.
2. the formula food being applicable to patients with diabetes mellitus according to claim 1, is characterized in that being made up of following raw material:
Buckwheat 37%, Semen Tritici aestivi fiber 29%, hawthorn 12%, the root of kudzu vine 1%, oligoisomaltose 3%, xylitol 3%, food additives 14.9%, vitamin premix 0.1%.
3. the formula food being applicable to patients with diabetes mellitus according to claim 1, is characterized in that being made up of following raw material:
Buckwheat 35%, Semen Tritici aestivi fiber 27%, hawthorn 10%, the root of kudzu vine 2%, oligoisomaltose 5%, xylitol 5%, food additives 15.7%, vitamin premix 0.3%.
4. the formula food being applicable to patients with diabetes mellitus according to claim 1, is characterized in that being made up of following raw material:
Buckwheat 33%, Semen Tritici aestivi fiber 25%, hawthorn 8%, the root of kudzu vine 3%, oligoisomaltose 7%, xylitol 7%, food additives 16.5%, vitamin premix 0.5%.
5. the formula food being applicable to patients with diabetes mellitus according to claim 1,2,3 or 4, is characterized in that described vitamin premix is Cobastab in every 100g vitamin premix
1containing 2mg, Cobastab
2containing 2mg, Cobastab
6containing 2mg, vitamin A is containing 0.5mg, and vitamin C is containing 195.5mg, and surplus is maltodextrin.
6. the formula food being applicable to patients with diabetes mellitus according to claim 5, is characterized in that described food additives are powdered phospholipid.
7. make the method being applicable to the formula food of patients with diabetes mellitus according to claim 6, it is characterized in that comprising following preparation method step:
(1). the impurity in the root of kudzu vine, hawthorn, foreign matter and the raw material that do not meet quality standard are carried out picking picking cleaning, drop into the purified water adding material quantity 10 times carry out immersion 30 minutes by picking the raw material after picking cleaning, soak well and decoct 1 hour at 100 DEG C of temperature, extract 2 hours at 100 DEG C of temperature again, last temperature 80 DEG C, 2 hours are concentrated under pressure-0.08Mpa, centrifugal spray drying is carried out to during relative density 1.1, dried crushing material is become 100 object powders, seals up for safekeeping for subsequent use in the material charging feedstock bucket after pulverizing;
(2). the impurity in buckwheat, foreign matter and the raw material that do not meet quality standard are carried out picking picking, then the buckwheat chosen is put into drying equipment and carry out drying, temperature controls at 110 DEG C, 30 minutes time, lower the temperature after dried, dried buckwheat is broken into 100 object powders, for subsequent use sealing up for safekeeping in the material charging feedstock bucket after pulverizing;
(3). it is for subsequent use that the buckwheat of the root of kudzu vine processed, haw thorn extract and process to add in mixer Homogeneous phase mixing 15 minutes, and standard is uniform powder;
(4). it is for subsequent use powdered phospholipid, xylitol, oligoisomaltose to be added in mixer Homogeneous phase mixing 15 minutes, and standard is uniform powder;
(5). Cobastab
1, Cobastab
2, Cobastab
6, that VC, VA to add in mixer Homogeneous phase mixing 15 minutes is for subsequent use, standard is uniform powder;
. by the (3) step and the (4) walk mixed material to add in mixer Homogeneous phase mixing 15 minutes for subsequent use, standard is uniform powder;
(7). (5) will walk and (6) walk mixed material with and add in mixer that to carry out Homogeneous phase mixing 15 minutes for subsequent use, standard is uniform powder, and preparation completes.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510057275.3A CN104621574A (en) | 2015-02-04 | 2015-02-04 | Formula food suitable for diabetic patients and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510057275.3A CN104621574A (en) | 2015-02-04 | 2015-02-04 | Formula food suitable for diabetic patients and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104621574A true CN104621574A (en) | 2015-05-20 |
Family
ID=53201222
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510057275.3A Pending CN104621574A (en) | 2015-02-04 | 2015-02-04 | Formula food suitable for diabetic patients and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104621574A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106260381A (en) * | 2016-08-29 | 2017-01-04 | 益科路博(天津)科技有限公司 | A kind of resveratrol pressed candy of applicable diabetes patient and preparation method thereof |
CN107080249A (en) * | 2016-06-30 | 2017-08-22 | 健糖(北京)健康管理有限公司 | A kind of edible formula food of confession diabetic population and its preparation technology |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101653282A (en) * | 2009-08-27 | 2010-02-24 | 杨波 | Solid beverage suitable for patients with diabetes mellitus |
CN102860553A (en) * | 2012-09-11 | 2013-01-09 | 四川玖玖爱食品有限公司 | Buckwheat miscellaneous-grain beverage and production method thereof |
CN103169080A (en) * | 2013-03-11 | 2013-06-26 | 太原市素有苦荞食品有限公司 | Fagopyrum tataricum nutrition powder and its preparation technology |
CN103535712A (en) * | 2012-07-18 | 2014-01-29 | 天津珍吾堂食品有限公司 | Process for manufacturing food for specific dietary for diabetes mellitus |
WO2014085923A1 (en) * | 2012-12-07 | 2014-06-12 | Taylor Carla G | Inhibition of both facilitative and active glucose uptake mechanisms by compounds in common buckwheat contributes to reduced glucose transport |
CN104068080A (en) * | 2014-05-06 | 2014-10-01 | 娄志 | Biscuit for diabetics |
-
2015
- 2015-02-04 CN CN201510057275.3A patent/CN104621574A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101653282A (en) * | 2009-08-27 | 2010-02-24 | 杨波 | Solid beverage suitable for patients with diabetes mellitus |
CN103535712A (en) * | 2012-07-18 | 2014-01-29 | 天津珍吾堂食品有限公司 | Process for manufacturing food for specific dietary for diabetes mellitus |
CN102860553A (en) * | 2012-09-11 | 2013-01-09 | 四川玖玖爱食品有限公司 | Buckwheat miscellaneous-grain beverage and production method thereof |
WO2014085923A1 (en) * | 2012-12-07 | 2014-06-12 | Taylor Carla G | Inhibition of both facilitative and active glucose uptake mechanisms by compounds in common buckwheat contributes to reduced glucose transport |
CN103169080A (en) * | 2013-03-11 | 2013-06-26 | 太原市素有苦荞食品有限公司 | Fagopyrum tataricum nutrition powder and its preparation technology |
CN104068080A (en) * | 2014-05-06 | 2014-10-01 | 娄志 | Biscuit for diabetics |
Non-Patent Citations (3)
Title |
---|
凌关庭: "《保健食品原料手册(第二版)》", 31 May 2007, 化学工业出版社 * |
支国安等: "糖尿病人专用预混合面粉的研究开发", 《粮食与饲料工业》 * |
母义明明: "《糖尿病》", 31 August 2014, 军事医学科学出版社 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107080249A (en) * | 2016-06-30 | 2017-08-22 | 健糖(北京)健康管理有限公司 | A kind of edible formula food of confession diabetic population and its preparation technology |
CN106260381A (en) * | 2016-08-29 | 2017-01-04 | 益科路博(天津)科技有限公司 | A kind of resveratrol pressed candy of applicable diabetes patient and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108112996A (en) | A kind of alimentation composition for controlling diabetes B crowd hyperglycaemia and improving immunity | |
CN102113648A (en) | Special dietary noodle applicable to people suffering from 'five-high' metabolic syndrome and preparation method thereof | |
CN106912960A (en) | A kind of hypoglycemia healthcare food and preparation method thereof | |
CN108522969A (en) | A kind of compound nutritional pulvis that can be hypoglycemic | |
CN102113652A (en) | Special dietary extruded rice applicable to patients suffering from 'five-high' metabolic syndrome and preparation method thereof | |
CN104257727A (en) | Soft capsule for relieving visual fatigue and processing method | |
CN107613998A (en) | Contain the prevention and treatment pharmaceutical composition or healthy food of the metabolic disease of Pleurotus ferulae water extract as active ingredient | |
CN104621574A (en) | Formula food suitable for diabetic patients and preparation method thereof | |
CN101341915B (en) | Multifunctional health tea | |
CN105124576A (en) | Preparation method of health food with assistant blood sugar-decreasing effect | |
CN102640922B (en) | Black-and-white nutritional health-care rice for reducing blood sugar and preparation method thereof | |
CN104957618A (en) | Eye-protecting capsules with dendrobium officinale and fish oil | |
CN102499366B (en) | Health-care food for adjusting blood fat and preventing fatigue | |
CN107998271A (en) | A kind of systematicness reduces Chinese medicine and health products that blood glucose repairs damaged cell | |
CN104225228B (en) | A kind of Chinese medicine preparation for being used to adjust blood glucose | |
JP6167357B1 (en) | Diabetes mellitus improvement preventive | |
CN105831730A (en) | Krill oil composite special dietary food for reducing hypertension, hyperglycemia and hyperlipidemia | |
CN105031248A (en) | Health care product which contains Se-enriched cordyceps and is capable of assisting in blood sugar level regulation | |
CN105191859A (en) | Production method of low-cholesterol potassium-rich carotene-rich egg | |
CN108936689A (en) | Adjust the oral solution and preparation method thereof of immunity | |
CN104971146A (en) | Jackfruit powder with blood sugar and blood fat regulating function and preparation method of jackfruit powder | |
CN107927739A (en) | A kind of food enrichment and preparation method thereof | |
CN106666350A (en) | Blood glucose lowering rice porridge | |
CN108142784A (en) | A kind of wheat composite flour and preparation method thereof | |
CN106912929A (en) | A kind of health food nutritional agents and preparation method with anti-fatigue effect |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150520 |